See every side of every news story
Published loading...Updated

Bluebird, at risk of default, agrees to take-private deal

Summary by biopharmadive.com
The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of what it was once worth.

2 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Just Drinks broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)